Suchergebnisse - "Corso, Alessandro"

PubPharm (155)

21

Management of infectious complications in multiple myeloma patients : Expert panel consensus-based recommendations

enthalten in: Blood reviews | 2019

von Girmenia, C. | Cavo, M. | Offidani, M. | +6

22

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2019

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

23

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3) : a double-blind, randomised, placebo-controlled phase 3 trial

enthalten in: Lancet (London, England) | 2019

von Dimopoulos, M. | Gay, F. | Schjesvold, F. | +124

CommentIn: Lancet. 2019 Jan 19;393(10168):204-205. - PMID 30545778

24

Disorganization and real-world functioning in schizophrenia : Results from the multicenter study of the Italian Network for Research on Psychoses

enthalten in: Schizophrenia research | 2018

von Rocca, P. | Galderisi, S. | Rossi, A. | +91

25

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2018

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

26

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2018

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

27

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2018

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

28

Multiple Myeloma Treatment in Real-world Clinical Practice : Results of a Prospective, Multinational, Noninterventional Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2018

von Mohty, M. | Terpos, E. | Mateos, M. | +130

29

The advantages of switch to subcutaneous bortezomib in the real life

enthalten in: Leukemia & lymphoma | 2018

von Mangiacavalli, S. | Cocito, F. | Ferretti, V. | +3

30

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

enthalten in: The New England journal of medicine | 2018

von Mateos, M. | Dimopoulos, M. | Cavo, M. | +127